Nav: Home

New Regenstrief studies report drug focused approach insufficient to manage ICU delirium

March 05, 2019

INDIANAPOLIS - The results of two new Regenstrief Institute trials published in the Journal of the American Geriatrics Society underscore and confirm the need to look to options other than medication to lower the duration or severity of delirium in intensive care unit (ICU) patients.

"Looking at our large studies and other recent work, including several trials we and others have conducted focusing on haloperidol, the most commonly used antipsychotic in the ICU, we can now conclusively say that the role of antipsychotics for management of delirium severity or duration is nonexistent," said Regenstrief Institute Investigator Babar A. Khan, M.D., who led one of two new studies of pharmacological management of delirium in the ICU testing low doses of haloperidol. In addition to his Regenstrief appointment, Dr. Khan is a faculty member of Indiana University School of Medicine.

"It's clear that the problem of delirium in ICU patients is complex and not easily reversible," said Regenstrief Institute Investigator Noll Campbell, PharmD, MS, who led the concurrent study on deprescribing of drugs thought to cause or prolong delirium in the ICU. "For example, our study showed that implementing electronic alerts that advise deprescribing -- to reduce the dose or discontinue a medication linked to delirium -- had no impact on clinical outcomes." In addition to his Regenstrief appointment, Dr. Campbell is a faculty member of Purdue University's College of Pharmacy.

Delirium, a sudden and serious change in brain function often manifesting as confusion, occurs in as many as three quarters of the five million Americans treated in a medical or surgical ICU annually.

Individuals who experience delirium in the ICU are more likely to have longer hospital stays, more hospital-associated complications and higher risk of hospital readmission. They also have a greater likelihood of dying for up to a year after their hospital stay than ICU patients who did not experience delirium and also are more likely to experience cognitive impairment and have ongoing problems with daily activities.

"Our extensive research in these two high quality and pragmatic trials enables us to make significant conclusions," said Regenstrief Institute Investigator Malaz Boustani, M.D., MPH. "First, in order to reduce the burden of delirium we need to explore biological pathways other than the antipsychotic ones such as exploring the therapeutic role of the inflammatory pathways. Second, in order for us to reduce exposure to harmful medications such as anticholinergics and benzodiazepines, we need to adopt insights from behavioral economics to develop more effective deprescribing strategies."

Dr. Boustani is the founding director of the Center for Health Innovation and Implementation Science, a joint venture among Regenstrief, IU School of Medicine and the Indiana Clinical and Translational Sciences Institute; an associate director of IU Center for Aging Research and the Richard M. Fairbanks Professor in Aging Research at IU School of Medicine.

The pharmacologic interventions studied in these trials, focusing on drugs with known adverse effects on the brain, did not benefit ICU patients, suggesting that other approaches to delirium care in these extremely ill individuals should be investigated. Drs. Khan, Campbell and Boustani call for further study of non-pharmacological methods to combat delirium in ICU patients including waking them sooner and more frequently, earlier mobilization and exposure to music.
-end-
In addition to Regenstrief Institute investigator Babar A. Khan, M.D., authors of "Pharmacological Management of Delirium in the Intensive Care Unit: A Randomized Pragmatic Clinical Trial" are Dr. Campbell and Dr. Boustani along with Regenstrief Institute Investigator Sikandar H. Khan, D.O.; and Anthony J. Perkins, M.S.; Sujuan Gao, Ph.D.; Mark O. Farber, M.D.; Sophia Wang, M.D. and Ben L. Zarzaur, M.D., MPH, all of IU School of Medicine.

In addition to Regenstrief Institute investigator Noll Campbell, PharmD, MS, authors of "Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit" are Dr. Babar A. Kahn and Dr. Boustani along with Regenstrief Institute Investigator Sikandar H. Khan D.O; and Anthony J. Perkins, MS; Sujuan Gao, Ph.D.; Mark O. Farber, M.D., and Sophia Wang, M.D., all of IU School of Medicine.

Both Regenstrief studies were funded by the National Institute on Aging through awards on which Dr. Boustani is a principal investigator.

Regenstrief Institute

Related Delirium Articles:

Difficulties diagnosing delirium in older adults after surgery
Experts still don't always agree on delirium symptoms or diagnoses, even when they are assessing the same symptoms in the same people.
Drug believed to reduce postoperative pain and delirium does neither
Anesthesiologists routinely give surgery patients low doses of the drug ketamine to blunt postoperative pain and reduce the need for opioid drugs.
Study: Ketamine doesn't affect delirium or pain after surgery
A new study, with an accompanying editorial, published today in The Lancet sought to discover what effect ketamine has on delirium and pain -- two serious postoperative complications.
Program helps reduce risk of delirium, hospital length of stay for older patients undergoing surgery
Older patients who underwent major abdominal surgery and received an intervention that included nutritional assistance and early mobilization were less likely to experience delirium and had a shorter hospital stay, according to a study published by JAMA Surgery.
Delirium is associated with 5-fold increased mortality in acute cardiac patients
Delirium is associated with a five-fold increase in mortality in acute cardiac patients, according to research published today in European Heart Journal: Acute Cardiovascular Care.
Delirium in critically ill children admitted to intensive care units common and widespread
One out of every four children admitted to intensive care units (ICUs) for critical illness develops delirium, according to an international study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Predicting long-term cognitive decline following delirium
Evidence suggests that experiencing delirium after surgery can lead to long-term cognitive decline in older adults.
IU Center for Aging Research develops novel ICU delirium severity assessment tool
The Indiana University Center for Aging Research has developed and validated a novel easy-to-administer tool to score and track delirium severity in the ICU, enabling clinicians to make better decisions about the brain health of ICU patients.
Delirium could accelerate dementia-related mental decline
When hospitalized, people can become acutely confused and disorientated. This condition, known as delirium, affects one-quarter of older patients and new research by UCL and University of Cambridge shows it may have long-lasting consequences, including accelerating the dementia process.
Delirium an insidious, deadly threat to nursing home residents
A comprehensive review of research published today in The Journal of the American Osteopathic Association finds delirium to be an often-undiagnosed syndrome, affecting nearly 18 percent of long-term care residents, with a staggering 40 percent one-year mortality rate.

Related Delirium Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".